The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Rabies Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
The global Rabies Vaccine market size is expected to reach US$ 1229.1 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Rabies Vaccine in various end use industries. The expanding demands from the Pre-exposure Prophylaxis and Post-exposure Prophylaxis, are propelling Rabies Vaccine market. Vero Cell Rabies Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the BHK segment is estimated at % CAGR for the next seven-year period.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rabies Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rabies Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rabies Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rabies Vaccine covered in this report include GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT and Hissen, etc.
The global Rabies Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Global Rabies Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rabies Vaccine market, Segment by Type:
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Global Rabies Vaccine market, by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
The global Rabies Vaccine market size is expected to reach US$ 1229.1 million by 2029, growing at a CAGR of 4.0% from 2023 to 2029. The market is mainly driven by the significant applications of Rabies Vaccine in various end use industries. The expanding demands from the Pre-exposure Prophylaxis and Post-exposure Prophylaxis, are propelling Rabies Vaccine market. Vero Cell Rabies Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the BHK segment is estimated at % CAGR for the next seven-year period.
Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.
China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.
In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Rabies Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Rabies Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Rabies Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Rabies Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Rabies Vaccine covered in this report include GSK (Novartis), Sanofi-Pasteur, Chengda, Yisheng, Prcmise, VACN, Changsheng, BCHT and Hissen, etc.
The global Rabies Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Global Rabies Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rabies Vaccine market, Segment by Type:
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others
Global Rabies Vaccine market, by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Rabies Vaccine Market Overview
1.1 Rabies Vaccine Product Overview
1.2 Rabies Vaccine Market Segment by Type
1.2.1 Vero Cell Rabies Vaccine
1.2.2 BHK
1.2.3 Chick Embryo Cell Rabies Vaccine
1.2.4 Others
1.3 Global Rabies Vaccine Market Size by Type
1.3.1 Global Rabies Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Rabies Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Rabies Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rabies Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Rabies Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Rabies Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Type (2018-2023)
2 Global Rabies Vaccine Market Competition by Company
2.1 Global Top Players by Rabies Vaccine Sales (2018-2023)
2.2 Global Top Players by Rabies Vaccine Revenue (2018-2023)
2.3 Global Top Players by Rabies Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Rabies Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rabies Vaccine Market Competitive Situation and Trends
2.5.1 Rabies Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Rabies Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rabies Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Rabies Vaccine Market
2.8 Key Manufacturers Rabies Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rabies Vaccine Status and Outlook by Region
3.1 Global Rabies Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Rabies Vaccine Historic Market Size by Region
3.2.1 Global Rabies Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Rabies Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Rabies Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Rabies Vaccine Forecasted Market Size by Region
3.3.1 Global Rabies Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Rabies Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Rabies Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Rabies Vaccine by Application
4.1 Rabies Vaccine Market Segment by Application
4.1.1 Pre-exposure Prophylaxis
4.1.2 Post-exposure Prophylaxis
4.2 Global Rabies Vaccine Market Size by Application
4.2.1 Global Rabies Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Rabies Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Rabies Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rabies Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Rabies Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Rabies Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Rabies Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Rabies Vaccine Sales Breakdown by Application (2018-2023)
5 North America Rabies Vaccine by Country
5.1 North America Rabies Vaccine Historic Market Size by Country
5.1.1 North America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Rabies Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Rabies Vaccine Sales in Value by Country (2018-2023)
5.2 North America Rabies Vaccine Forecasted Market Size by Country
5.2.1 North America Rabies Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Rabies Vaccine Sales in Value by Country (2024-2029)
6 Europe Rabies Vaccine by Country
6.1 Europe Rabies Vaccine Historic Market Size by Country
6.1.1 Europe Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Rabies Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Rabies Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Rabies Vaccine Forecasted Market Size by Country
6.2.1 Europe Rabies Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Rabies Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Rabies Vaccine by Region
7.1 Asia-Pacific Rabies Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Rabies Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Rabies Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Rabies Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Rabies Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Rabies Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Rabies Vaccine Sales in Value by Region (2024-2029)
8 Latin America Rabies Vaccine by Country
8.1 Latin America Rabies Vaccine Historic Market Size by Country
8.1.1 Latin America Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Rabies Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Rabies Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Rabies Vaccine Forecasted Market Size by Country
8.2.1 Latin America Rabies Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Rabies Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Rabies Vaccine by Country
9.1 Middle East and Africa Rabies Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Rabies Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Rabies Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Rabies Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Rabies Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Rabies Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Rabies Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK (Novartis)
10.1.1 GSK (Novartis) Company Information
10.1.2 GSK (Novartis) Introduction and Business Overview
10.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK (Novartis) Rabies Vaccine Products Offered
10.1.5 GSK (Novartis) Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi-Pasteur Rabies Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Chengda
10.3.1 Chengda Company Information
10.3.2 Chengda Introduction and Business Overview
10.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Chengda Rabies Vaccine Products Offered
10.3.5 Chengda Recent Development
10.4 Yisheng
10.4.1 Yisheng Company Information
10.4.2 Yisheng Introduction and Business Overview
10.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Yisheng Rabies Vaccine Products Offered
10.4.5 Yisheng Recent Development
10.5 Prcmise
10.5.1 Prcmise Company Information
10.5.2 Prcmise Introduction and Business Overview
10.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Prcmise Rabies Vaccine Products Offered
10.5.5 Prcmise Recent Development
10.6 VACN
10.6.1 VACN Company Information
10.6.2 VACN Introduction and Business Overview
10.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 VACN Rabies Vaccine Products Offered
10.6.5 VACN Recent Development
10.7 Changsheng
10.7.1 Changsheng Company Information
10.7.2 Changsheng Introduction and Business Overview
10.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Changsheng Rabies Vaccine Products Offered
10.7.5 Changsheng Recent Development
10.8 BCHT
10.8.1 BCHT Company Information
10.8.2 BCHT Introduction and Business Overview
10.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BCHT Rabies Vaccine Products Offered
10.8.5 BCHT Recent Development
10.9 Hissen
10.9.1 Hissen Company Information
10.9.2 Hissen Introduction and Business Overview
10.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hissen Rabies Vaccine Products Offered
10.9.5 Hissen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rabies Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rabies Vaccine Industrial Chain Analysis
11.4 Rabies Vaccine Market Dynamics
11.4.1 Rabies Vaccine Industry Trends
11.4.2 Rabies Vaccine Market Drivers
11.4.3 Rabies Vaccine Market Challenges
11.4.4 Rabies Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rabies Vaccine Distributors
12.3 Rabies Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
